Poland· PL-100117236

Dermatol Gemi

A other dermatologicals product containing bismuthi subgallas, registered in Poland by Grzegorz Nowakowski Przedsiębiorstwo Produkcji Farmaceutycznej "GEMI". The same ATC class is registered in 6 of our 19 countries.

ATC D11AX

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedDermatol GemiATCD11AXREGISTER NO.PL-100117236PACKS LISTED2CHECKEDSeptember 27, 2026

Where it is registered

Bismuthi subgallas is registered in 6 of 19 countries.

Countries holding a registration under ATC D11AX (other dermatologicals), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 5 of them publish a price we can compare per daily dose

Bismuthi subgallas · ATC D11AX

6 / 19 countries

  • Belgiumprice
  • Ireland
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

URPL (Poland)
Active substance
Bismuthi subgallas
Manufacturer
Grzegorz Nowakowski Przedsiębiorstwo Produkcji Farmaceutycznej "GEMI"
Country
Poland (PL)
ATC code
D11AX
ATC class
Other dermatologicals
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 2

  • gtin
    05909994358911
  • gtin
    05905903778818

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Bismuthi subgallas in 3 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All bismuthi subgallas products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/3f534850-c5c4-4884-8333-2b0912ddafab
GET /v1/drugs/3f534850-c5c4-4884-8333-2b0912ddafab?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Proszek do stosowania na skórę",
  "source": "urpl",
  "strength": "-",
  "packaging": "05909994358911 ¦ OTC ¦ 21709\n1 sasz. 2 g\n05905903778818 ¦ OTC ¦ 133272\n1 sasz. 5 g",
  "substance": "Bismuthi subgallas 100 g",
  "common_name": "Bismuthi subgallas",
  "pl_product_id": "100117236",
  "pozwolenie_nr": "IL-3589/ChF",
  "auth_procedure": "NAR",
  "authorisation_validity": "Bezterminowe"
}

See everything about bismuthi subgallas.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.